My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2190

    1.

    Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.

    Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, Holst JJ, Ferrannini E.

    Diabetes. 2008 May;57(5):1340-8. Epub 2007 Dec 27.PMID: 18162504 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.

    Muscelli E, Mari A, Natali A, Astiarraga BD, Camastra S, Frascerra S, Holst JJ, Ferrannini E.

    Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1144-50. Epub 2006 Feb 14.PMID: 16478775 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

    Rask E, Olsson T, Söderberg S, Holst Jj J, Tura A, Pacini G, Ahrén B.

    Metabolism. 2004 May;53(5):624-31.PMID: 15131768 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.

    Osei K, Gaillard T, Schuster DP.

    Diabetes Care. 1997 Mar;20(3):396-404.PMID: 9051394 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.

    Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K.

    Diabetologia. 2008 May;51(5):853-61. Epub 2008 Mar 4.PMID: 18317726 [PubMed - indexed for MEDLINE]Related articles

    6.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

    Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA.

    J Clin Endocrinol Metab. 2005 Jan;90(1):493-500. Epub 2004 Oct 13.PMID: 15483086 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

    Greenbaum CJ, Prigeon RL, D'Alessio DA.

    Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

    Festa A, Williams K, Hanley AJ, Haffner SM.

    Diabetes. 2008 Jun;57(6):1638-44. Epub 2008 Mar 10.PMID: 18332099 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.

    Ritzel R, Schulte M, Pørksen N, Nauck MS, Holst JJ, Juhl C, März W, Schmitz O, Schmiegel WH, Nauck MA.

    Diabetes. 2001 Apr;50(4):776-84.PMID: 11289042 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Vølund A, Holst JJ, Krarup T.

    Diabetes. 2007 Aug;56(8):1951-9. Epub 2007 May 18.PMID: 17513701 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.

    Park SW, Ihm SH, Yoo HJ, Park JY, Lee KU.

    Diabetes Res Clin Pract. 1997 Sep;37(3):165-71.PMID: 9306037 [PubMed - indexed for MEDLINE]Related articles

    13.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

    Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

    J Clin Lab Anal. 2007;21(2):85-90.PMID: 17385686 [PubMed - indexed for MEDLINE]Related articles

    15.

    Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.

    Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ.

    Diabetes. 2008 Mar;57(3):678-87. Epub 2007 Dec 5.PMID: 18057091 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2003 May;52(5):565-72.PMID: 12759885 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.

    Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L.

    Diabetologia. 2000 Dec;43(12):1476-83.PMID: 11151756 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus]

    Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese. PMID: 17686259 [PubMed - indexed for MEDLINE]Related articles

    19.

    Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes.

    Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E.

    Diabet Med. 2008 Jun;25(6):671-7.PMID: 18544104 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity